Financhill
Back

Structure Therapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60

GPCR
Structure Therapeutics, Inc.

Last Price:
$68.75
Seasonality Move:
-4.31%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight selling pressure.

Structure Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 64.76 Buy
20-day SMA: 54.7 Buy
50-day SMA: 41.07 Buy
200-day SMA: 26.34 Buy
8-day EMA: 65.27 Buy
20-day EMA: 57.2 Buy
50-day EMA: 45.22 Buy
200-day EMA: 31.64 Buy

Structure Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.55 Buy
Relative Strength Index (14 RSI): 70.17 Buy
Chaikin Money Flow: -284110 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.64 - 66.86) Buy
Bollinger Bands (100): (17.09 - 46.21) Buy

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Structure Therapeutics, Inc. Stock

Is Structure Therapeutics, Inc. Stock a Buy?

GPCR Technical Analysis vs Fundamental Analysis

Buy
60
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy or a Sell?

Structure Therapeutics, Inc. Stock Info

Market Cap:
4B
Price in USD:
69.69
Share Volume:
745.4K

Structure Therapeutics, Inc. 52-Week Range

52-Week High:
94.90
52-Week Low:
13.22
Buy
60
Structure Therapeutics, Inc. (GPCR) is a Buy

Structure Therapeutics, Inc. Share Price Forecast

Is Structure Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Structure Therapeutics, Inc.

Is Structure Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Technical Analysis of Structure Therapeutics, Inc.

Should I short Structure Therapeutics, Inc. stock?

* Structure Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.